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Background: A strong association exists between the use of tamsulosin and the occurance of intraoperative floppy
iris syndrome. Several methods were advocated to overcome the progressive intraopertive miosis.
Our purpose was to investigate the effect of a mydriatic-cocktail soaked cellulose sponge on perioperative pupil
diameter in tamsulosin-treated patients undergoing elective cataract surgery.
Methods: Patients using tamsulosin were dilated either with mydriatic-cocktail soaked sponge (group 1) or with
conventional eyedrop regimen (group 2). Control patients not taking any α1 adrenergic receptor inhibtors were also
dilated with mydriatic sponge (group 3).
In all groups oxybuprocain 0.4%, cocain 4%, tropicamide 1%, phenylephrine 10%, diclophenac 0.1% along with
chloramphenicol 0.5% were used preoperatively.
Pupil diameter (mm) was measured preoperatively, after nucleus delivery, and before IOL implantation. Adverse
effects associated with the use of sponge, minor and major intraoperative complications, the use of iris retractors
and operation time were recorded.
Differences in general between groups were analyzed with a one way analysis of variance (ANOVA); differences
between groups in proportions were assessed by Fisher’s exact test.
Results: Mean pupil diameter (mm) was preopertively: 7.52 ± 1.21, 7.30 ± 1.55 and 7.99 ± 0.96 (ANOVA: p = 0.079);
after nucleus delivery: 6 ± 1.20, 6.29 ± 1.12 and 6.52 ± 0.81 (ANOVA: p = 0.123); before IOL implantation: 5.46 ± 1.06,
5.83 ± 1.09 and 6.17 ± 0.89 (ANOVA: p = 0.0291).
No adverse effect related to sponge use was detected. Frequency of minor complications, and iris hook use was
similar in the two tamsulosin treated group. Operation time did not differ significantly in the three groups.
Conclusion: We have found that using a mydriatic cocktail-soaked wick – an alternative way to achieve intraoperative
mydriasis for cataract surgery – was as effective and safe as the conventional repeated eyedrops regiment for
tamsulosin treated patients.
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Proper perioperative mydriasis and anaesthesia are pre-
requisite to successful cataract surgery.
Cataract operation may be performed using different
preoperative protocols which should be determined ac-
cording to the needs and preference of the patient, the
anaesthesia professionals and the surgeon [1]. Adequate
pupil dilation is even more crucial for patients who are
at risk of limited pupillary function.
Intraoperative floppy iris syndrome (IFIS) associated
with tamsulosin – a systemic α1 adrenergic receptor an-
tagonist (α1-ARA) - was first described by Chang and
Campbell in 2005. It is characterised by the triad of (1)
flaccid iris stroma that undulates and billows in response
to ordinary intraocular fluid currents, (2) tendency for
the iris stroma to prolapse towards the phaco and side-
port incisions, and (3) a progressive intraoperative pupillary
miosis during cataract surgery [2].
IFIS may lead to the constriction of the surgical field
which increases vision-threatening complications of
cataract surgery such as iris stroma damage, posterior
capsular rupture, and loss of vitreous, particularly when
surgeons are unaware of patient’s medical history [3-5].
Systemic α-blockers are used to treat the urinary
symptoms of benign prostatic hypertrophy (BPH). These
agents relax smooth muscle in the prostate and bladder.
This effect is utilized to improve symptoms associated
with BPH [6,7]. However, this α-blockade can influence
iris motility also.
A strong association was found between IFIS and tam-
sulosin [8] – a selective α1A and α1D adrenergic receptor
antagonist, which is a common therapeutic option for
BPH. Several studies showed a risk of IFIS as high as
53.3%-93.8% with tamsulosin use [2,9-14].
Various strategies were advocated for patients taking
α1-ARA to achieve appropriate mydriasis and to over-
come the progressive miosis such as: preoperative top-
ical atropine, intracameral injection of epinephrine,
careful wound construction, mechanical pupil dilation,
gentle hydrodissection, low-flow fluidic settings, and bi-
manual irrigation-aspiration [15-17].
Preoperative discontinuation of α1 adrenergic receptor
antagonist medication has an unclear role in inhibiting
the occurernce of IFIS [2,5,12,17-20].
All of the above techniques serve as preventive mea-
sures to minimize the risk of IFIS, however they do not
eliminate its occurrence.
Previous studies indicated that the use of a wick pre-
soaked in standard mydriatic and non-steroidal anti-
inflammatory drugs was as effective or superior to the
conventional repeated instillation of drops before cata-
ract surgery in a mixed cohort [21-24].
In our study we investigated the efficacy of a mydriatic




Male patients taking tamsulosin due to benign prostatic
hypertrophy, attending elective cataract surgery at Thy-
Mors Hospital (Thisted, Denmark) were enrolled in our
study from October 2012 until December 2012 (n = 65).
Along with the study group patients we enrolled 31 con-
trol males not receiving any α1 adrenergic receptor antag-
onist medication. Medical and ophthalmic history was
recorded at the preoperative visit. Previous ocular surgery
(1), posterior synechiae (2) and the use of drops other than
artificial tears (3) were exclusion criteria (n = 60). The
study group was subdivided randomly into two equal sized
groups (n = 30), using sealed envelope method. The
randomization was carried out by the anaesthetic nurse in
the anaesthetic room. Surgeons were masked for the ran-
domisation but not for the use of tamsulosin due to re-
gional safety guidelines. 30 patients were dilated using the
mydriatis cocktail-soaked sponge (group 1), and 30 pa-
tients were dilated using conventional repeated eyedrops
regimen (group 2). We had to cancel two patients from
group 2 in the operation room due to fact that they could
not lie flat and still. Control patients (group 3; n = 31)
were also dilated with mydriatic-cocktail soaked sponge
(Additional file 1).
The study adhered to the tenets of the Declaration of
Helsinki, and was approved by The North Denmark Region
Committee on Health Research Ethics (N-20120049).
Written informed consent was obtained from all parti-
cipants in this study. The patients in the figures gave
written consent for publication of their image.
Preoperative preparation
In all groups oxybuprocain 0.4%, cocain 4%, tropicamide
1% (Minims® Tropicamide, Bausch&Lomb), phenylephrine
10% (Minims® Phenylephrine hydrochloride 10%, Bausch
& Lomb), diclophenac 0.1% (Diclofenacnatrium Stulln,
Pharma Stulln GmbH, Stulln, Germany) along with chlor-
amphenicol 0.5% eyedrops were used preoperatively.
For the sponge groups (group 1 and group 3) 4 mm ×
5 mm pieces of cellulose wicks (BD Visitec™, Eye Fluid
Wick, Becton Dickinson, Dublin, Ireland) were prepared
and submerged in a mix of the above solutions with
1:1:1:1:1:1 ratio. Sterile mydriatic solution was prepared
daily.
After topical administration of one drop oxybuprocain
0.4% anaesthesia a piece of soaked wick was inserted in
the outer lower fornix for 30 minutes (Figures 1 and 2).
Any adverse effect associated with the use of sponge
such as corneal abrasion, allergic reaction or wick mi-
grating to the upper fornix was recorded.
Figure 1 Mydriatic cocktail-soaked sponge inserted in the outer
lower fornix (arrow).
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we applied the above drops 3 times with 10 minutes
intervals.
Surgeons were not involved in the dilatation process.
Surgical technique and intraoperative measurements
Patients recieved a drop of oxybuprocain 0.4% before insert-
ing the specula, and before initial wound construction.
An oblique or a temporal 2.75 mm clear cornea, 3-
step incision was used along with two 1.5 mm side inci-
sions. After injection of viscoelastic materials (Duovisc,
Alcon Fort Worth, TX, USA) for anterior chamber
maintenance, a continuous curvilinear capsulorrhexis
(CCC) and hydrodissection were performed. The lens
was phacoemulsified using either devide-and-conquer or
horizontal chop technique and irrigation aspiration was
performed bimanually. In each case we implanted a sin-
gle piece foldable acryllic lens (Biocomfold 92, Morcher,Figure 2 Assesing pupil dilation after 30 minutes. Arrow points
towards the sponge.Stuttgart, Germany) in the capsular bag. After complete
removal of viscoelastic materials, the clear corneal and
side incisions were hydrosealed. At completion of sur-
gery, 1 mg intracameral cefuroxime was administred.
Pupil diameter was measured with 0.5 mm increments
in the horizontal plain preoperatively, after nucleus
delivery, and before IOL implantation using Geuder
Castroviejo caliper (Geuder AG, Heidelberg, Germany)
(Figure 3). The use of flexible iris retractors (Alcon La-
boratories, Inc., Fort Worth, TX, USA) were recorded.
In case of iris retractor use, patients were excluded from
further pupillary mesaurements, and statistic. Intraoper-
ative miosis was assesed between the preoperative meas-
urement and the measurement after nucleus delivery
(miosis 1); between the measurement after nucleus deliv-
ery and measurement before IOL implantation (miosis
2); and between the preaoperative measurement and the
measurement before IOL implanatation (total intraoper-
ative miosis).
Intraoperative iris billowing, iris prolapse, minor intraop-
erative complications (iris damage, iris bleeding, retained
cortex) and major intraoperative complications (anterior/
posterior capsular tear, vitreous loss, nuclear fragment/cor-
tical material loss and zonular dialysis) were recorded.
The presence of IFIS was recorded upon the occur-
ance of any symptom, according to its definition.
Duration of operation was measured from the initial
wound construction until removal of the specula.
Statistical analysis
The size of the study was decided from the following
power considerations. With 25 patients in each of two
groups, a 0.8 mm difference between groups will be rec-
ognized by an unpaired t-test with 80% probability assum-
ing a within group standard deviation of approximately
1 mm.Figure 3 Intraoperative measurement of pupillary diamater
with Castoviejo caliper.
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diameter, miosis, and operation time) were analyzed with
a one-way analysis of variance (ANOVA), and differ-
ences between specific groups (group 1 vs. group 2 and
group 1 vs. group 3) were assessed by suitable contrasts
assuming normality and variance homogeneity. Mean
and 95% confidence intervals are given for each com-
parison. Normal distribution was assessed by qq plots
and variance homogeneity by robust variance test.
Differences between groups in proportions (hyperten-
sion, diabetes, clear corneal incision location, IFIS signs,
complications and use of iris retractors) were assessed
by Fisher’s exact test.
Results
Table 1 summarizes preoperative data, comparing results
from group 1 (patients using tamsulosin, dilated with
mydriatic-cocktail soaked sponge) with group 2 (patients
using tamsulosin, dilated with conventional repeated
eyedrops regimen) and group 1 with group 3 (control
patients, dilated with mydriatic-cocktail soaked sponge)
respectively.
Mean age ± standard deviarion (SD) was 78.60 ± 10.35
years in group 1, 76.64 ± 6.85 years in group 2, and 78.48 ±
5.84 in group 3. One way ANOVA showed no significant
age difference between the three groups (p = 0.5777).
No adverse effect related to mydriatic-sponge use was
experienced.
Table 2 shows the intraoperative data comparing
group 1 with group 2 and group 1 with group 3
respectively.
One way ANOVA test did not show significant differ-
ence in pupillary diameter between groups preopera-
tively (p = 0.079) and after nucleus delivery (p = 0.123),
however we found significant difference before IOL im-
plantation (p = 0.0291).
We found no significant difference between the three
groups in miosis 1 (p = 0.4763), miosis 2 (p = 0.0760)
and in miosis total (p = 0.1678).
In the two tamsulosin treated groups, the patients di-
lated with a mydriatic wick had greater preoperative
mydriasis in comparison with patients receiving conven-
tional eyedrops regimen, however, this difference was notTable 1 Preoperative data
Patient group and pupil dilation methods
Group 1. n = 30 Group 1 vs. Group 2
Mean age ± SD (years) 78.6 ± 10.35 p = 0.350; 95% CI −6.10-2.18
Hypertension 17/30 p = 1.000
Diabetes 10/30 p = 0.243
Group 1. Tamsulosin treated patients and cocktail-soaked sponge dilation.
Group 2. Tamsulosin treated patients and conventional drop dilation.
Group 3. Control patients and cocktail-soaked sponge dilation.
n = number of patients, SD = standard deviation, p = value of significance, 95% CI =significant. This slight difference disappeared at later
stages of surgery.
There was even distribution of temporal and oblique
clear corneal incision in all 3 groups.
In group 1, iris retractors were used before completing
nucleus delivery in a single case and two additional cases
after nucleus delivery. In group 2, we retracted iris with
hooks in two patients after clear corneal incisions. In
group 3, we had to facilitate surgery by using iris retrac-
tors with a patient before completing nucleus delivery.
IFIS signs were observed in a significantly higher de-
gree in group 1 compared with group 3.
Minor (3/30, 2/28 and 1/31 respectively) and major
(1/30, 0/28 and 0/31 respectively) complication rate was
similar in all groups.
Mean operation time was shorter in group 3 (15.26 ±
3.21 minutes) than in the two tamsulosin treated groups
(15.87 ± 3.21 minutes and 16.61 ± 2.59 minutes) respect-
ively, but the difference was not significant (p = 0.1547).
Discussion
Cataract surgery is more challenging in patients taking
α1-ARA due to poor and unstable perioperative mydria-
sis [2,6,8,16]. History of tamsulosin use among patients
undergoing cataract surgery was estimated around 3% in
the United States [25-27]. Although several pre- and in-
traoperative methods are used to overcome this prob-
lem, IFIS remains one of the pitfalls of cataract surgery.
In our study we investigated the efficacy of mydriatic
cocktail-soaked sponge pupil dilation in patients using
tamsulosin due to benign prostatic hypertrophy. Our re-
sults indicated that regardless of the preoperative protocol,
patients with tamsulosin treatment show poorer peri-
operative mydriasis in comparisons with control subjects.
Comparing the two groups having the mydriatic
cocktail-soaked sponge pupil dilation preoperatively
(group 1 vs. group 3), patients with tamsulosin treat-
ment showed significantly smaller pupil diameters after
nucleus delivery and before IOL implantation but not
preoperatively.
Patients in group 1 showed significantly higher degree of
miosis between our second and third pupil measurement
(miosis 2) in comparison with group 3 (p = 0.024). TheseGroup 2. n = 28 Group 3. n = 31 Group 1 vs. Group 3
76.64 ± 6.85 78.48 ± 5.84 p = 0.954; 95% CI −4.15-3.92
15/28 17/31 p = 1.000
10/28 6/31 p = 0.518
95% confidence interval.
Table 2 Intraoperative data
Patient group and pupil dilation methods
Group 1. n = 30 Group 1 vs. Group 2 Group 2. n = 28 Group 3. n = 31 Group 1 vs. Group 3
Pupillary diameter ± SD (mm)
Preoperatively 7.52 ± 1.21 p = 0.492; 95% CI −0.83 - 0.40 7.30 ± 1.55 7.99 ± 0.96 p = 0.124; 95% CI −0.13 - 1.06
After nucleous delivery 6 ± 1.20 p = 0.247; 95% CI −0.23 - 0.87 6.29 ± 1.12 6.52 ± 0.81 p = 0.042; 95% CI 0.20 - 1.08
Before IOL implantation 5.46 ± 1.06 p = 0.178; 95% CI −0.17 - 0.90 5.83 ± 1.09 6.17 ± 0.89 p = 0.008; 95% CI 0.19 - 1.22
Miosis 1 ± SD (mm) 1.52 ± 0.88 p = 0.330; 95% CI −0.64 - 0.22 1.31 ± 0.75 1.55 ± 0.74 p = 0.874; 95% CI −0.38 - 0.44
Miosis 2 ± SD (mm) 0.61 ± 0,45 p = 0.349; 95% CI −0.35 - 0.12 0.5 ± 0.47 0.35 ± 0.37 p = 0.024; 95% CI −0.39 - 0.03
Total intraoperative
miosis ± SD (mm)
2.18 ± 0.91 p = 0.073; 95% CI −0.83 - 0.04 1.79 ± 0.67 1.88 ± 0.78 p = 0.156; 95% CI −0.72 - 0.18
Location of tunnel wound t:15 o:15 p = 1.000 t:14 0: 14 t:16 o:15 p = 1.000
IFIS signs
Iris billowing 19/30 p = 0.583 20/28 5/31 p = 0.000
Iris prolaps 7/30 p = 1.000 7/28 1/31 p = 0.026
Intraoperative complications
Minor 3/30 p = 1.000 2/28 1/31 p = 0.354
Major 1/30 p = 1.000 0/28 0/31 p = 0.492
Use of iris retractors 3/30 p = 1.000 2/28 1/31 p = 0.354
Mean operation time ± SD
(minutes)
15.87 ± 3.21 p = 0.256; 95% CI −0.65-2.42 16.75 ± 2.69 15.26 ± 2.87 p = 0.421; 95% CI −2.10-089
Group 1. Tamsulosin treated patients and cocktail-soaked sponge dilation.
Group 2. Tamsulosin treated patients and conventional drop dilation.
Group 3. Control patients and cocktail-soaked sponge dilation.
n = number of patients, SD = standard deviation, IOL = intraocular lens, t = temporal incision, o = oblique incision, IFIS = intraoperative floppy iris syndrome.
p = value of significance, 95% CI = 95% confidence interval.
Statistically significant differences between groups are highlighted in bold.
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tamsulosin treatment develop progressive intraoperative
pupillary miosis during cataract surgery [2,3,10]. In con-
trast, Casuccio et al. found that pupil diameter was signifi-
cantly smaller both preoperatively and postopoperatively
in patients taking tamsulosin compared with their control
group, however both exclusion criteria and their mydriatic
regimen were different [27].
We had a uniform distribution of oblique and tem-
poral wounds in each group, which limits observational
bias between groups. It has been shown that the anterior
chamber is deeper superiorly than temporally, and there-
fore a superior approach may be preferred in some cases
to minimize the risk or iris prolapse [28,29]. However
there is a general consensus that meticulous wound con-
struction – 2-step or 3-step incision, appropriate lenght
of the wound, and the location of entry into the anterior
chamber in relation to the iris plane – is essential in pre-
venting intraoperative iris prolapse [29-32].
The incidence of iris prolapse was similar in our two
tamsulosin treated group (23% and 25% respectively).
This incidence is lower that in the largest prospective
study (n = 167) published to date [10], however α1-ARA
medication is only one of the many predisposing factors
[29]. Iris billowing – a hallmark of IFIS – was found insimilar percentage in the two tamsulosin treated group
as in two previous studies [11,24].
The frequency of iris retractors use was similar in the
two tamsulosin groups (3/30 vs. 2/28), and lower than in
the previously pubished results of Blouin et al., and Issa
et al. 42.6% and 38% respectively [12,33].
Minor complication rate was higher in the two tamsu-
losin treated groups (10% and 7.1%) than in the control
group (3.2%), however this difference was not signifi-
cants which is probably due to the low sample size. A
single patient treated with tamsulosin had posterior cap-
sule rupture without vitreous loss in group 1. Patients
having minor or major complications did not have sig-
nificantly smaller preoperative pupillary diameter. Minor
complication rate was similar as in the recently pub-
lished studies, however lower than in earlier studies; this
is probably due to the increasing awareness of IFIS and
to our unmasked study fashion [2,3,10,14,27,34,35]. The
relatively high incidence of minor complication in the
control group might be related to small sample size or
to the high prevalance of systemic hypertension, which
was proposed as a possible cofounder of IFIS [13].
We use mydriatic cocktail-soaked sponge pupil dila-
tion as a standard method in our cataract surgery proto-
col. In our practice, the use of mydriatic sponge beside
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able saving in nursing resources along with medicine
expenses, in comparison with conventional repeated eye-
drops method. We observed that this method is as effect-
ive as the conventional drop regimen in a mixed case
cohort (unpubished results), but we have not found any
previous publication indicating that this method may be
suitable for high risk patients such as patients taking
tamsulosin.
Our results show that the sponge was as effective in
achiving sufficient periopereative mydriasis in tamsulo-
sin treated patients as the conventional repeated eye-
drops method. The use of mydriatic soaked sponge was
not associated with any advers effect, and showed similar
rate of minor complications as found in the conventional
repeated eyedrops group.
Previously, three randomised controlled studies inves-
tigated the use of mydriatic drug delivery by a soaked
wick placed in the lower fornix [22-24]. In all these stud-
ies, similar exclusion criteria were applied as in our
study, however, in the first study patients with diabetes
and very dark irides, and in the latest study, patients
with systemic hypertension and ischemic heart disease
were also excluded. These studies did not registered the
use of α1-ARA medicines.
Only the study by McCormick indicated a clear time-
frame for pupil dilation: the pledget sponge was removed
after 20 minutes. In our protocol, we terminated pupil
dilation 30 minutes after initiation.
In the first study preoperative pupil diamater was mea-
sured 1–4 hours after initiation of pupil dilation with a
wick soaked in mydriatic drops (Tropicamide 1%, Phenile-
phine 2.5% and Diclophenac sodium 0.1%), but no intra-
operative measurement was taken. In the second study
horisontal pupil diamater was measured in milimeters
prior to surgery, and 40 minutes after commencement of
mydriatic regime (Tropicamide 1%, Phenylephrine 2.5%
and Atropine 1%) without any intraoperative pupil asses-
ment. In the latest study pupillary diameters were mea-
sured 15, 30, 45 minutes after placing in the lower fornix a
sponge - immersed in the cocktail regiment consisting of
1:1:1:1 ratio of 2.5% phenylephrine, 0.5% moxifloxacin, 1%
cyclopetolate and 0.03% flurbiprofen eye drops. Pupil size
was also assessed intraoperatively after nucleous delivery
and IOL implantation.
Preoperative pupil diameter was higher in the study by
Dubois et al., similar to McCormick et al. and lower in by
Sengupta et al. than in our study, however all three studies
used different mydriatic cocktail regime and duration of
sponge use. We observed similar pupil diameters after
nucleous delivery as in the latest study (6.20 mm).
The study by Dubois et al. and McCormick et al.
found that the cocktail-soaked sponge protocol leads to
similar results as the conventional drop application. Thestudy by Sengupta et al. showed that results were super-
ior with the soaked-wick method.
Our study group of tamsulosin patients had much
higher risk of developing progressive intraoperative
miosis - a component of IFIS - than a mix cohort. Vari-
ous studies indicated up to hundred times higher inci-
dence of IFIS in patients with α1-ARA medication.
None of the previous three studies investigated the pres-
ence of IFIS or intraoperative complications.
Pupil dilation by mydriatic cocktail-soaked sponge
showed to be effective in all three studies without any
adverse event that might be related to the use of sponge.
The sponge primarily used to absorb and drain blood
and fluid from the surgical field during ophthalmic pro-
cedures, but alternatively it serves as mydriatic and an-
aesthetic reservoir from which drugs diffuse down along
its concentration gradient into the ocular tissues.
Our study has certain limitations. First surgeons were
not masked to use of tamsulosin due to institutional
quality regulations that require the preoperative check-
ing of patient medication, which may lead to observa-
tional bias. Second, the detection of IFIS (iris billowing)
relied on surgeon’s subjective assessment, however this
limitation is common in most studies, and the incidence
of IFIS in our study was similar to previous findings.
Third, we had a relatively small sample size which might
have an impact on statistical analysis, however the num-
ber of tamsulosin treated subjects in our study was simi-
lar to most studies published so far.
Conclusion
In conclusion we have found that using a mydriatic
cocktail-soaled wick – an alternative way to achieve intra-
operative mydriasis for cataract surgery – was as effective
and safe as the conventional repeated eyedrops regiment
in tamsulosin using patients. Though this method did not
provide clinical difference or benefit compared to the con-
ventional method, it may serve as a safe and timesaving
alternative preoperative protocol even for high risk tamsu-
losin treated patients.
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